Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAttard, Stephen-
dc.contributor.authorSoler, Doriette-
dc.contributor.authorSoler, Paul-
dc.identifier.citationMalta Medical Journal. 2012, Vol.24(1), p. 21-30en_GB
dc.description.abstractIntroduction: Cerebral function monitoring (CFM) is a simplified EEG device that is used to monitor cerebral function at the cot-side. Various studies have shown its value in detecting neonatal encephalopathy and electrographic seizures, prognostication of neonatal cerebral insults, assessment of response to anticonvulsant therapy and in selecting encephalopathic infants for therapeutic hypothermia. This paper describes our preliminary experience with this monitoring device at Mater Dei Hospital, and a draft of a protocol for its clinical application. Methods: Fourteen recordings were performed on neurologically normal and abnormal term neonates. The quality of the records and their correlation with other imaging and standard EEG findings was assessed. A dataset including technical and clinical particulars of these cases was then compiled, analyzed and discussed. Results: Amplitude aEEG traces were recorded from a total of 14 patients, 4 of whom were normal term or near term infants, and 10 were infants with a neurological abnormality. All records were of satisfactory quality, and all showed very high impedance levels. Five out of 11 neurologically-abnormal patients had signs of seizure activity on CFM. A technical fault caused high impedance level in the first 2 traces. Annotations were generally lacking. Five out of 10 infants with CNS problems had clinical seizures of which 4 had electrographic seizures on CFM, 4 had electrographic seizures on formal EEG, and 3 had abnormal MRI findings. Conclusion: Our local experience has confirmed the usefulness of CFM monitoring in the setting of a neonatal intensive care unit. Despite some initial problems with high impedance levels and electrode attachment, the tracings obtained were reproducible and of good quality. Almost half of the neurologically-abnormal neonates showed signs of seizure activity on CFM with good correlation with clinical and standard EEG. The timely diagnosis enabled the clinicians to confirm seizure activity, initiate anticonvulsant therapy and monitor the response. Staff training is vital in order to improve utilisation of CFM in neonatal practice.en_GB
dc.publisherMalta Medical Journalen_GB
dc.subjectEncephalopathy, Neonatalen_GB
dc.subjectElectroencephalography -- In infancy and childhooden_GB
dc.subjectNeonatal intensive care -- Maltaen_GB
dc.titleCerebral function monitoring in term or near term neonates at MDH : preliminary experience and proposal of a guidelineen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
Appears in Collections:MMJ, Volume 24, Issue 1
MMJ, Volume 24, Issue 1
Scholarly Works - FacM&SPae

Files in This Item:
File Description SizeFormat 
2012.Vol24.Issue1.A4.pdfCerebral function monitoring in term or near term neonates at MDH: preliminary experience and proposal of a guideline332.45 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.